Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USP "introductory" patient leaflets

Executive Summary

U.S. Pharmacopeia says it will issue patients' pharmaceutical information leaflets for new drugs within one month after they are approved. Based on FDA-approved physician labeling, the leaflets "are intended to fill an immediate need for information on a temporary basis until a full monograph is developed through USP's consensus process'and added to USP-Dispensing Information, the organization said. The program was approved by USP's Drug Information Division Executive Committee.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS023616

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel